Thomas U. Barton
Angel · New York
Board director at 4 startups that filed Form D raises since late 2024, mostly in New York.
- Stages
- Series A, Series B
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jun 2024
Focus
Biotech & PharmaHealthcareRecent portfolio activity
Sources
- SEC Form D: RenovionMar 28, 2023
- SEC Form D: Aletheia BioTherapeuticsAug 16, 2023
- SEC Form D: ImmunoGenesisApr 3, 2024
- SEC Form D: MyrtelleJun 10, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.